Sharechat Logo

Summerset lifts fourth-quarter sales by 50 percent , annual sales top 400

Wednesday 8th January 2014 1 Comment

Text too small?

Summerset Group, whose shares have made more than three times the gains of the NZX 50 Index in the past 12 months, said sales of occupation rights jumped 50 percent in the fourth quarter from a year earlier.

The retirement village operator had 60 new sales and 51 resales in the final three months of 2013, up from 43 and 31 sales respectively a year earlier.

Sales in the year rose 21 percent to 402, made up of 228 new and 174 resales, the first time annual sales have topped 400. Annual gross cash from sales rose to $131 million from $102 million in 2012.

Summerset shares last trade at $3.44 and have advanced 52 percent in the past 12 months compared to a 16.5 percent gain for the NZX 50. The stock is rated a 'buy' based on the consensus of five analysts polled by Reuters, with a median price target of $3.55.

Listed retirement village operators have been one of the best-performing sectors on the bourse in the past year as they pursue growth by developing new sites and benefit from the demographics of an aging population.

Ryman Healthcare has surged 65 percent in the past 12 months and is now rated 'hold' and Metlifecare is up 31 percent and still has a 'buy' rating.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

On 8 January 2014 at 5:31 pm Don said:
Good growth figures, don't mind the poor yield as they invest retained earnings for growth in assets & income.
Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors